Ann: Drilling Confirms Significant Ni-Co Discovery at Itapitanga, page-120

First 120 Last

Share
Profile

Follow
dilson55

1,225 Posts.

45

30/05/18

09:23

Post #: 33365992
Share

Originally posted by Messiah ↑

Why?
Do you think they received the response from IBMBio, reviewed it, confirmed if there were any changes to the vast regulations, discussed it with the board - then lined up discussions with NMA - and that negative information all aligned perfectly for a release the day BEFORE a substantial drilling announcement, which was released the day before a NiCo conference which we're speaking at?

My opinion is that was a manufactured release to soften the SP impact and it failed miserably.

You need an unbaised and objective view when dealing with information that is presented. Rose coloured glasses in this business will see you lose money.

My view is the Company is largely driven/overseen by accountants and a lawyer. They do have the best interest of SH at heart, but you still need to be able to see through it.

Read the response to the speeding ticket. They can justify the delay to the release of any info and this will be the same. They can hold an ANN for as long as they deem it 'not' to have reasonable grounds for it to affect someones investment.

Their opinion of affecting a persons reason to invest is different to mine, and I have my opinions and I will be critical.

I dont suddenly devalue the company or its prospects - but it's my right as a shareholder to call some things out for what they appear to be - and I will. I will ask for a copy of the determination from IBMBio before reevaluation of my opinion(s). If that document is transparent I should be provided with a copy, don't you think?

Too many people can't be critical enough of the companies they invest in (and remain invested) - they are too scared to be openly critical and sell out quietly and say nothing. I appreciate any rebuttal to my input as it challenges my own opinion, so that (your comment) is appreciated..

Expand

I'll say it again, I hope you have some evidence. All I'm seeing here is circumstantial and pure conjecture.

I have no issue questioning management. But what your doing is purporting your opinion as facts. Good luck with that.

CTM Price at posting: 1.4¢ Sentiment: Buy Disclosure: Held
4 Upvote

0 Great analysis

Reply

Top Stories

RCE

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

ASX Market Open: ASX200 to open weak on Wall Street losses, as US investors factor in a lower Fed rate cut next month | October 8, 2024

CHM

Leukaemia patient shows complete response in Chimeric Therapeutics' latest trial

NEU

Neuren sees FDA greenlight for 3rd trial into children with Phelan-McDermid syndrome

Arika to pump $3.2M into gold exploration at WA's Yundamindra following strong maiden program

There are more pages in this discussion • 197 more messages in this thread...

First 120 Last

Add CTM (ASX) to my watchlist

(20min delay)
Last 52.0¢		Change 0.005(0.97%)		Mkt cap ! $258.2M

Open	High	Low	Value	Volume
51.5¢	54.0¢	50.0¢	$156.9K	305.2K

Buyers (Bids)

No.	Vol.	Price($)
1	2685	51.5¢

Sellers (Offers)

Price($)	Vol.	No.
52.0¢	47650	1

View Market Depth

No.	Vol.	Price($)
1	2685	0.515
1	5000	0.505
2	34864	0.500
1	21549	0.495
2	60000	0.490

Price($)	Vol.	No.
0.520	47650	1
0.530	91042	1
0.535	10000	1
0.540	59322	5
0.550	2287	1

Last trade - 16.10pm 07/10/2024 (20 minute delay)

CTM (ASX) Chart

Ann: Drilling Confirms Significant Ni-Co Discovery at Itapitanga, page-120

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

ASX Market Open: ASX200 to open weak on Wall Street losses, as US investors factor in a lower Fed rate cut next month | October 8, 2024

Leukaemia patient shows complete response in Chimeric Therapeutics' latest trial

Neuren sees FDA greenlight for 3rd trial into children with Phelan-McDermid syndrome

Arika to pump $3.2M into gold exploration at WA's Yundamindra following strong maiden program

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Ann: Drilling Confirms Significant Ni-Co Discovery at Itapitanga, page-120

Top Stories

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

ASX Market Open: ASX200 to open weak on Wall Street losses, as US investors factor in a lower Fed rate cut next month | October 8, 2024

Leukaemia patient shows complete response in Chimeric Therapeutics' latest trial

Neuren sees FDA greenlight for 3rd trial into children with Phelan-McDermid syndrome

Arika to pump $3.2M into gold exploration at WA's Yundamindra following strong maiden program

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News